BL-8040 + Placebo
Phase 1Completed 0 watching 0 views this week💤 Quiet
25
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB)
Conditions
Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB)
Trial Timeline
Aug 1, 2014 → Jul 1, 2015
NCT ID
NCT02073019About BL-8040 + Placebo
BL-8040 + Placebo is a phase 1 stage product being developed by BioLineRx for Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB). The current trial status is completed. This product is registered under clinical trial identifier NCT02073019. Target conditions include Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB).
Hype Score Breakdown
Clinical
10
Activity
5
Company
2
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02073019 | Phase 1 | Completed |